Stefan Kaehler
About Stefan Kaehler
Stefan Kaehler is the Executive Director, Qualified Person for Pharmacovigilance EU & UK at Bristol Myers Squibb, with over 30 years of experience in global medicinal product risk management and pharmacovigilance.
Title and Current Position
Stefan Kaehler currently serves as the Executive Director, Qualified Person for Pharmacovigilance EU & UK at Bristol Myers Squibb in Österreich. In this role, he is responsible for overseeing pharmacovigilance activities across Europe and the UK.
Previous Experience at Celgene
Stefan Kaehler has held multiple executive roles at Celgene from 2010 to 2021, including Executive Director and Senior Director positions in Global Drug Safety and Risk Management, GMP-QP. He worked in various capacities such as EEA QPPV, Global Lead Safety Scientist, and Deputy QPPV, primarily in the UK and Vienna. His tenure at Celgene involved key responsibilities in risk management, safety standards, and ensuring compliance with global regulations.
Education and Accreditations
Stefan Kaehler has an extensive educational background with advanced degrees from Leopold-Franzens Universität Innsbruck, where he studied Pharmakologie und Toxikologie, and achieved the titles Dr.rer.nat et Mag-pharm. He also attended Harvard Business School in 2011. In 2016, he achieved the venia docendi (Priv.Doz) in Pharmakologie und Toxikologie.
Key Achievements
Over his career, Stefan Kaehler has received multiple awards including those for Excellence in Delivering Exceptional Results and for Living Business Ethical Values. He has successfully set up Compliance, Market Access, Regulatory, and Drug-Safety Offices, handling license inspections without any observations. He has also played a significant role in the fast implementation of risk minimization measures in the EEA and has been awarded for Outstanding Career Contribution.
Global Pharmacovigilance Expertise
With over 30 years of experience, Stefan Kaehler has a profound background in GMP, GDP, GLP, GCP, and GVP inspections. His career includes the establishment and implementation of new pharmacovigilance legislation and the creation of Pharmacovigilance System Master Files. He has been a Qualified Person for Pharmacovigilance (QPPV) in several ARAB region countries including Egypt, UAE, Saudi Arabia, Jordan, Kuwait, and Oman.